Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Financing Activities (2016)

Historic Cash from Financing Activities for Tenax Therapeutics (TENX) over the last 7 years, with Q4 2016 value amounting to $100160.0.

  • Tenax Therapeutics' Cash from Financing Activities rose 20000.0% to $100160.0 in Q4 2016 from the same period last year, while for Jun 2016 it was -$151945.0, marking a year-over-year change of. This contributed to the annual value of $99.9 million for FY2024, which is 63601.59% up from last year.
  • According to the latest figures from Q4 2016, Tenax Therapeutics' Cash from Financing Activities is $100160.0, which was up 20000.0% from -$100160.0 recorded in Q4 2015.
  • In the past 5 years, Tenax Therapeutics' Cash from Financing Activities ranged from a high of $73.6 million in Q1 2014 and a low of -$100160.0 during Q4 2015
  • Moreover, its 5-year median value for Cash from Financing Activities was $3.7 million (2012), whereas its average is $27.9 million.
  • Per our database at Business Quant, Tenax Therapeutics' Cash from Financing Activities surged by 269574.7% in 2012 and then tumbled by 12636.21% in 2015.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Cash from Financing Activities stood at $60.1 million in 2012, then increased by 11.53% to $67.1 million in 2013, then plummeted by 100.02% to -$16008.0 in 2014, then plummeted by 525.69% to -$100160.0 in 2015, then surged by 200.0% to $100160.0 in 2016.
  • Its Cash from Financing Activities stands at $100160.0 for Q4 2016, versus -$100160.0 for Q4 2015 and -$51785.0 for Q3 2015.